Scripps Clinic

Oct 2, 2024 | jamanetwork.com | Marat Fudim |Barry A. Borlaug |Scripps Clinic

Key PointsQuestion  What is the feasibility, safety, and efficacy of endovascular right-sided splanchnic nerve ablation for volume management (SAVM)? Finding  In this phase 2, double-blind, randomized clinical trial including 90 patients, there were no differences in adverse events between groups. The primary efficacy end point did not differ between SAVM and sham.

Sep 26, 2024 | academic.oup.com | Scripps Clinic

Recent advances in techniques, technologies and proven superiority over anti-arrhythmic drugs have made catheter ablation the cornerstone of management for atrial fibrillation (AF), which has shown a steady increase in prevalence in the ageing population worldwide. The aim of therapeutic interventions is to achieve stable sinus rhythm that would improve the quality of life and reduce the risk of AF-associated complications.

Jul 23, 2024 | radcliffecardiology.com | Scripps Clinic |Christine L. Shen |Sanjeev Bhavnani

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.

Oct 25, 2023 | respiratory-research.biomedcentral.com | Scripps Clinic

ReferencesSung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49. Google Scholar  Thai AA, et al. Lung cancer. The Lancet. 2021;398(10299):535–54. Google Scholar  Reck M, Rabe KF. Precision diagnosis and treatment for Advanced Non-small-cell Lung Cancer. N Engl J Med. 2017;377(9):849–61. CAS  PubMed  Google Scholar  Kris MG, et al.

Jan 24, 2023 | frontiersin.org | Scripps Clinic

Diana V. Maslov1*, Quinne Sember1, Jason Cham1 and Munveeer Bhangoo1 1Scripps Clinic, United States Provisionally accepted: The final, formatted version of the article will be published soon. Prostate cancer is the most common cancer in men. About 6% of those diagnosed will develop metastatic disease. Unfortunately, metastatic prostate cancer is fatal. Prostate cancer can be castration sensitive or castration resistant.